# Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma

> **NCT05888636** · — · UNKNOWN · sponsor: **Regina Elena Cancer Institute** · enrollment: 200 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** ChIP-seq, NGS, ATAC-seq

## Key facts

- **NCT ID:** NCT05888636
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-18
- **Primary completion:** 2023-11-11
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-03-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05888636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05888636, "Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05888636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*